Pacer Advisors’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.38M | Sell |
359,658
-21,715
| -6% | -$468K | 0.02% | 487 |
|
|
2025
Q4 | $7.62M | Sell |
381,373
-83,249
| -18% | -$1.63M | 0.02% | 563 |
|
|
2025
Q3 | $8.48M | Sell |
464,622
-48,889
| -10% | -$953K | 0.02% | 523 |
|
|
2025
Q2 | $10.3M | Sell |
513,511
-202,009
| -28% | -$3.88M | 0.03% | 482 |
|
|
2025
Q1 | $13M | Sell |
715,520
-2,216,593
| -76% | -$39.7M | 0.03% | 412 |
|
|
2024
Q4 | $50.9M | Buy |
2,932,113
+121,162
| +4% | +$2.33M | 0.11% | 199 |
|
|
2024
Q3 | $54.3M | Sell |
2,810,951
-547,610
| -16% | -$10.1M | 0.11% | 201 |
|
|
2024
Q2 | $55.1M | Sell |
3,358,561
-2,311
| -0.1% | -$35.9K | 0.12% | 193 |
|
|
2024
Q1 | $51.2M | Buy |
3,360,872
+1,631,888
| +94% | +$25.6M | 0.12% | 189 |
|
|
2023
Q4 | $27.7M | Buy |
1,728,984
+1,727,534
| +119,140% | +$24.2M | 0.08% | 249 |
|
|
2023
Q3 | $18.8K | Sell |
1,450
-938,022
| -100% | -$12.2M | ﹤0.01% | 2531 |
|
|
2023
Q2 | $12M | Sell |
939,472
-697,222
| -43% | -$8.73M | 0.05% | 334 |
|
|
2023
Q1 | $18.4M | Buy |
1,636,694
+98,040
| +6% | +$1.19M | 0.08% | 247 |
|
|
2022
Q4 | $20.4M | Buy |
1,538,654
+63,256
| +4% | +$832K | 0.1% | 165 |
|
|
2022
Q3 | $17.1M | Buy |
1,475,398
+371,034
| +34% | +$5.09M | 0.12% | 137 |
|
|
2022
Q2 | $16.3M | Buy |
1,104,364
+383,060
| +53% | +$6.27M | 0.12% | 143 |
|
|
2022
Q1 | $14M | Buy |
721,304
+71,559
| +11% | +$1.28M | 0.11% | 172 |
|
|
2021
Q4 | $11.2M | Buy |
649,745
+216,046
| +50% | +$3.68M | 0.12% | 171 |
|
|
2021
Q3 | $7.25M | Sell |
433,699
-39,876
| -8% | -$597K | 0.09% | 257 |
|
|
2021
Q2 | $6.35M | Buy |
473,575
+187,368
| +65% | +$2.34M | 0.09% | 286 |
|
|
2021
Q1 | $3.42M | Buy |
286,207
+206,953
| +261% | +$2.5M | 0.06% | 357 |
|
|
2020
Q4 | $982K | Buy |
79,254
+34,318
| +76% | +$370K | 0.02% | 705 |
|
|
2020
Q3 | $470K | Buy |
44,936
+13,998
| +45% | +$178K | 0.01% | 1002 |
|
|
2020
Q2 | $433K | Buy |
30,938
+6,746
| +28% | +$91.8K | 0.01% | 734 |
|
|
2020
Q1 | $317K | Sell |
24,192
-40,858
| -63% | -$540K | 0.01% | 313 |
|
|
2019
Q4 | $921K | Sell |
65,050
-10,180
| -14% | -$125K | 0.04% | 581 |
|
|
2019
Q3 | $793K | Buy |
75,230
+17,867
| +31% | +$214K | 0.02% | 891 |
|
|
2019
Q2 | $835K | Sell |
57,363
-9,547
| -14% | -$135K | 0.02% | 866 |
|
|
2019
Q1 | $939K | Buy |
66,910
+25,687
| +62% | +$416K | 0.03% | 469 |
|
|
2018
Q4 | $719K | Buy |
41,223
+10,864
| +36% | +$176K | 0.03% | 105 |
|
|
2018
Q3 | $463K | Buy |
30,359
+20,605
| +211% | +$297K | 0.02% | 884 |
|
|
2018
Q2 | $135K | Buy |
9,754
+6,235
| +177% | +$93.4K | 0.01% | 1036 |
|
|
2018
Q1 | $59K | Buy |
3,519
+975
| +38% | +$15K | ﹤0.01% | 961 |
|
|
2017
Q4 | $36K | Buy |
+2,544
| New | +$33.9K | ﹤0.01% | 1048 |
|
Other funds holding INVA
VPM
VCM
SCM
SFM
Pacer Advisors's INVA Position: Q1 2026 in Review
Pacer Advisors reduced its Innoviva (INVA) stake by 5.7% in Q1 2026, selling an estimated $468K and leaving 359,658 shares worth $8.38M. The position accounts for 0.02% of the portfolio, ranked #487.
Pacer Advisors first reported a position in INVA in Q4 2017 and has held it in 34 quarters since. The position peaked at $55.1M in Q2 2024. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.
- Pacer Advisors held 359,658 shares of Innoviva worth $8.38M as of Q1 2026.
- Pacer Advisors sold 21,715 Innoviva shares in Q1 2026, an estimated $468K.
- Innoviva made up 0.02% of Pacer Advisors's portfolio in Q1 2026, its #487 holding.
- Pacer Advisors first reported a position in Innoviva in Q4 2017 and has held it in 34 quarters since.
- Pacer Advisors's Innoviva position peaked at $55.1M in Q2 2024.
- 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.